Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Cited In for PubMed (Select 17192355)

1.

Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Pharmacokinetic Parameters of Rosiglitazone in Healthy Subjects.

Braeckman RA, Stirtan WG, Soni PN.

Clin Pharmacol Drug Dev. 2015 Mar;4(2):143-148. Epub 2014 Dec 3.

2.

Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study.

Parrinello CM, Rastegar I, Godino JG, Miedema MD, Matsushita K, Selvin E.

Diabetes Care. 2015 Jul;38(7):1290-8. doi: 10.2337/dc15-0016. Epub 2015 Apr 7.

PMID:
25852205
3.

Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression.

Shao Y, Yuan G, Zhang J, Guo X.

Drug Des Devel Ther. 2015 Feb 18;9:1177-84. doi: 10.2147/DDDT.S79175. eCollection 2015.

4.

Arterial stiffness is inversely associated with a better running record in a full course marathon race.

Jung SJ, Park JH, Lee S.

J Exerc Nutrition Biochem. 2014 Dec;18(4):355-9. doi: 10.5717/jenb.2014.18.4.355. Epub 2014 Dec 29.

5.

Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis.

de Vries FM, Kolthof J, Postma MJ, Denig P, Hak E.

PLoS One. 2014 Nov 5;9(11):e111247. doi: 10.1371/journal.pone.0111247. eCollection 2014.

6.

High or low calcium intake increases cardiovascular disease risks in older patients with type 2 diabetes.

Huang JH, Tsai LC, Chang YC, Cheng FC.

Cardiovasc Diabetol. 2014 Aug 1;13:120. doi: 10.1186/s12933-014-0120-0.

7.

A comparative study of broccoli sprouts powder and standard triple therapy on cardiovascular risk factors following H.pylori eradication: a randomized clinical trial in patients with type 2 diabetes.

Mirmiran P, Bahadoran Z, Golzarand M, Zojaji H, Azizi F.

J Diabetes Metab Disord. 2014 May 28;13:64. doi: 10.1186/2251-6581-13-64. eCollection 2014.

8.

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting.

Ofori SN, Unachukwu CN.

Diabetes Metab Syndr Obes. 2014 May 23;7:159-68. doi: 10.2147/DMSO.S62320. eCollection 2014. Review.

9.

Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness.

Shin JA, Lee JH, Lim SY, Ha HS, Kwon HS, Park YM, Lee WC, Kang MI, Yim HW, Yoon KH, Son HY.

J Diabetes Investig. 2013 Jul 8;4(4):334-43. doi: 10.1111/jdi.12075. Epub 2013 May 28. Review.

10.

Association of classical risk factors and coronary artery disease in type 2 diabetic patients submitted to coronary angiography.

Bittencourt C, Piveta VM, Oliveira CS, Crispim F, Meira D, Saddi-Rosa P, Giuffrida FM, Reis AF.

Diabetol Metab Syndr. 2014 Mar 29;6(1):46. doi: 10.1186/1758-5996-6-46.

11.

Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).

Gerrits EG, Alkhalaf A, Landman GW, van Hateren KJ, Groenier KH, Struck J, Schulte J, Gans RO, Bakker SJ, Kleefstra N, Bilo HJ.

PLoS One. 2014 Feb 25;9(2):e89719. doi: 10.1371/journal.pone.0089719. eCollection 2014.

12.

High saturated-fat and low-fibre intake: a comparative analysis of nutrient intake in individuals with and without type 2 diabetes.

Breen C, Ryan M, McNulty B, Gibney MJ, Canavan R, O'Shea D.

Nutr Diabetes. 2014 Feb 3;4:e104. doi: 10.1038/nutd.2014.2.

13.

SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.

Hassing HC, Surendran RP, Derudas B, Verrijken A, Francque SM, Mooij HL, Bernelot Moens SJ, Hart LM, Nijpels G, Dekker JM, Williams KJ, Stroes ES, Van Gaal LF, Staels B, Nieuwdorp M, Dallinga-Thie GM.

Obesity (Silver Spring). 2014 May;22(5):1309-16. doi: 10.1002/oby.20682. Epub 2014 Jan 9.

14.

Clinical audit of diabetes care in the bahrain defence forces hospital.

Al-Baharna MM, Whitford DL.

Sultan Qaboos Univ Med J. 2013 Nov;13(4):520-6. Epub 2013 Nov 8.

15.

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study.

Brinton EA, Ballantyne CM, Bays HE, Kastelein JJ, Braeckman RA, Soni PN.

Cardiovasc Diabetol. 2013 Jul 9;12:100. doi: 10.1186/1475-2840-12-100.

16.

Prognostic utility of coronary computed tomographic angiography.

Otaki Y, Berman DS, Min JK.

Indian Heart J. 2013 May-Jun;65(3):300-10. doi: 10.1016/j.ihj.2013.04.028. Epub 2013 Apr 12. Review.

17.

Cardiorespiratory fitness levels and its correlates among adults with diabetes.

Loprinzi PD, Pariser G.

Cardiopulm Phys Ther J. 2013 Jun;24(2):27-34.

18.

Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics.

Aronow WS.

World J Cardiol. 2013 May 26;5(5):119-23. doi: 10.4330/wjc.v5.i5.119.

19.

Histamine H2 receptor antagonists for decreasing gastrointestinal harms in adults using acetylsalicylic acid: systematic review and meta-analysis.

Tricco AC, Alateeq A, Tashkandi M, Mamdani M, Al-Omran M, Straus SE.

Open Med. 2012 Aug 21;6(3):e109-17. Print 2012. Review.

20.

Mechanism of Roux-en-Y gastric bypass treatment for type 2 diabetes in rats.

Yu H, Zheng X, Zhang Z.

J Gastrointest Surg. 2013 Jun;17(6):1073-83. doi: 10.1007/s11605-013-2188-3. Epub 2013 Apr 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk